AbCellera Appoints Dr. Lynn Seely to its Board of Directors
VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) today announced the appointment of Lynn Seely, M.D., to its Board of Directors as an independent director. “Dr. Seely is a respected executive leader with a proven track record of successfully developing new medicines in endocrinology, oncology, and women’s health. I am pleased to welcome her to AbCellera’s [...]
VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) today announced the appointment of Lynn Seely, M.D., to its Board of Directors as an independent director. “Dr. Seely is a respected executive leader with a proven track record of successfully developing new medicines in endocrinology, oncology, and women’s health. I am pleased to welcome her to AbCellera’s [...]
Imported from verified news source. Source article provided by the listed publisher.
Source SummaryWhat we know from the source
VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) today announced the appointment of Lynn Seely, M.D., to its Board of Directors as an independent director. “Dr. Seely is a respected executive leader with a proven track record of successfully developing new medicines in endocrinology, oncology, and women’s health. I am pleased to welcome her to AbCellera’s [...]
Full external article text is not republished by default. Use the original publisher link for the complete story.
AttributionSource and transparency
Source article provided by the listed publisher. BC Post links to the original story for full context and attribution.
Financial PostPublished Jul 6, 2026Imported from newsdata.io
